Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation. [electronic resource]
- Oral oncology Mar 2016
- 68-74 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1879-0593
10.1016/j.oraloncology.2015.12.001 doi
Aged Antineoplastic Agents--therapeutic use Cetuximab--therapeutic use Combined Modality Therapy--methods Deglutition Disorders--epidemiology Female Humans Male Middle Aged Oropharyngeal Neoplasms--drug therapy Papillomaviridae Papillomavirus Infections--complications Quality of Life Surveys and Questionnaires Treatment Outcome